(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.

(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q43899644

about

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma Liver transplantation for advanced hepatocellular carcinoma Derivation of attenuation map for attenuation correction of PET data in the presence of nanoparticulate contrast agents using spectral CT imaging.Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.The value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases.Inflammatory and Ischemic Post Liver Transplant Complications Mimic Malignancy on 18F-FDG PET/CT.Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer C Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization

P2860

Q26750463-4761D3DD-3644-4FE3-8845-D4391C847418 Q27691331-CC5EFE0F-ABB3-41F2-A444-B7966F3C3C0F Q28067010-67AB7974-0717-4612-BF0D-63F06AF6371D Q28074653-57008C79-506E-45EC-8A7E-AA7F04D2A045 Q30797025-6E918631-7E09-4C7F-A8DF-06072ACD7204 Q34083775-38242BD3-0531-41A5-9BAF-E5BB27AB2BB7 Q36962089-0832FAD0-B036-4E9F-950E-FADCF36CDBCD Q38269467-FCF3F6FC-48D3-4BF6-B492-BB7081EE1DA5 Q38821374-5B3BA6A7-38BD-4830-8378-4D8F48EAAF57 Q39223475-1A132F3F-0807-4C16-B3AD-91C411A7C9CD Q41192134-FCBE75CB-45BD-48C1-88D6-85011E30F681 Q41706815-7BCC2F2B-566F-4A49-9832-C1DA5A9C5B99 Q48194435-73D56221-99EF-4FD7-8B9F-C6D688ACD37B Q49349115-E5527EA0-E3B7-4F50-BACD-8026EA891201 Q52988390-C5ACCDE6-1231-4E98-945C-D4455B5E6369 Q53028734-01A7F16D-BC1D-47DC-891F-08DB706EF596 Q57219629-C68CAA90-292F-46A0-89C6-C0FA5C2E348A Q58566698-D43D8644-F437-46A9-B988-B7D053E0B981 Q58739392-F04FEDB1-8D7D-4E0F-9419-30146F69343C

P2860

(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q43899644

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

(18)F-FDG-PET/CT predicts earl ...... for hepatocellular carcinoma.

@en

type

label

(18)F-FDG-PET/CT predicts earl ...... for hepatocellular carcinoma.

@en

prefLabel

(18)F-FDG-PET/CT predicts earl ...... for hepatocellular carcinoma.

@en

P1433

Q43899644-B65DA9E2-7D50-4B11-ACC2-0F66D4E8EADF

P1476

Q43899644-04884B26-E6F0-4932-AACD-4B91C612994A

P2093

Q43899644-29832A83-E495-41A1-A13D-B44ADFB953F2

Q43899644-5C541650-EA64-42BF-9219-84FF88317E20

Q43899644-7736FD1D-562C-49DA-ABDF-F191299CAD65

Q43899644-985F0022-4924-42A5-8690-2446B9D40B97

Q43899644-AD1EECF5-67EC-44F2-97F8-9A8843A59BA0

Q43899644-D2BEC12E-650F-4B14-93B6-8106BA8FDC3D

Q43899644-F5E9F1CC-A459-43EC-90BF-DA56E8F5EE27

P2860

Q43899644-0B75B5AB-1467-4807-B856-936A52A130DB

Q43899644-1577D73E-71D1-49E6-8F62-D5D237AF89B1

Q43899644-1AAC6A8E-52F1-4635-BC63-5298B8465547

Q43899644-2572854A-225B-45E7-9A57-FDEE69C5BFC8

Q43899644-33EECDB1-C459-4692-B11E-8649F0515B84

Q43899644-55C017CB-C322-4FB1-B60F-FD6F36EA6BA0

Q43899644-5F3A4E46-0232-4B53-8BBC-0457879B7840

Q43899644-65569D2F-BA89-4B10-9915-BBC53CECED58

Q43899644-85BC0180-A078-4654-B5C1-DF2912BFF429

Q43899644-9B379846-50CE-4EA5-8A40-7D75D07C0FA7

P304

Q43899644-DAEE562E-B4E9-431C-A1FF-A22A463DF4FA

P31

Q43899644-9E375135-59F7-4F74-BD8E-07332C6AEF43

P356

Q43899644-88860107-3EAC-4520-9526-9F7883D04691

P433

Q43899644-D063591D-71F3-4CE2-9D89-1B2C0D4161DF

P478

Q43899644-5C97C55C-4DDF-4791-B855-0985132C3162

P577

Q43899644-AA191BCD-B086-4E07-96F0-A1C79CE39E0E

P5875

Q43899644-EE428375-C9AF-47AD-91D4-B7EFE80D1F2F

P698

Q43899644-34AEB7C0-5084-4A41-8973-04070C7A64FE

P921

Q43899644-423F3757-3129-48E0-8378-37E5F460C0CA

P356

J.1432-2277.2012.01572.X

P1433

Transplant International

P1476

(18)F-FDG-PET/CT predicts earl ...... for hepatocellular carcinoma.

@en

P2093

Chulhan Kim

http://www.w3.org/2001/XMLSchema#string

Sang-Jae Park

http://www.w3.org/2001/XMLSchema#string

Seok-Ki Kim

http://www.w3.org/2001/XMLSchema#string

Seong Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Seung Duk Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Sik Han

http://www.w3.org/2001/XMLSchema#string

Young-Kyu Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.

Living-donor liver transplantation: 12 years of experience in Asia.

Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.

Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation.

Treatment of HCC in patients awaiting liver transplantation.

The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).

Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.

18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.

P304

50-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1432-2277.2012.01572.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232736361

http://www.w3.org/2001/XMLSchema#string

P698

23106431

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation